Dishman Carbogen Amcis Limited (DCAL) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.046x

Based on the latest financial reports, Dishman Carbogen Amcis Limited (DCAL) has a cash flow conversion efficiency ratio of 0.046x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs2.95 Billion ≈ $31.93 Million USD) by net assets (Rs63.65 Billion ≈ $688.35 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Dishman Carbogen Amcis Limited (DCAL) defensive interval to measure how many days the company can operate on defensive assets alone.

Dishman Carbogen Amcis Limited - Cash Flow Conversion Efficiency Trend (2005–2025)

This chart illustrates how Dishman Carbogen Amcis Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Dishman Carbogen Amcis Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Dishman Carbogen Amcis Limited ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Zen Voce
TWO:3581
-0.017x
Zhubo Design
SHE:300564
-0.027x
Bravo Mining Corp
V:BRVO
-0.005x
Nongshim Holdi
KO:072710
0.015x
Orbit Technologies Ltd
TA:ORBI
-0.056x
Chengdu Shengbang Seals Co.Ltd.
SHE:301233
0.020x
Sangam (India) Limited
NSE:SANGAMIND
0.009x
Fujian Nanwang Environment Protection Scien-Tech Co. Ltd. A
SHE:301355
N/A

Annual Cash Flow Conversion Efficiency for Dishman Carbogen Amcis Limited (2005–2025)

The table below shows the annual cash flow conversion efficiency of Dishman Carbogen Amcis Limited from 2005 to 2025. For the full company profile with market capitalisation and key ratios, see Dishman Carbogen Amcis Limited stock valuation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-03-31 Rs58.32 Billion
≈ $630.66 Million
Rs3.75 Billion
≈ $40.58 Million
0.064x -5.70%
2024-03-31 Rs56.27 Billion
≈ $608.59 Million
Rs3.84 Billion
≈ $41.52 Million
0.068x +49.05%
2023-03-31 Rs58.10 Billion
≈ $628.29 Million
Rs2.66 Billion
≈ $28.76 Million
0.046x -28.42%
2022-03-31 Rs55.49 Billion
≈ $600.10 Million
Rs3.55 Billion
≈ $38.38 Million
0.064x -28.91%
2021-03-31 Rs56.99 Billion
≈ $616.31 Million
Rs5.13 Billion
≈ $55.44 Million
0.090x -12.14%
2020-03-31 Rs57.15 Billion
≈ $618.06 Million
Rs5.85 Billion
≈ $63.28 Million
0.102x +95.28%
2019-03-31 Rs53.79 Billion
≈ $581.73 Million
Rs2.82 Billion
≈ $30.50 Million
0.052x +18.26%
2018-03-31 Rs51.07 Billion
≈ $552.34 Million
Rs2.26 Billion
≈ $24.49 Million
0.044x -29.48%
2017-03-31 Rs48.14 Billion
≈ $520.61 Million
Rs3.03 Billion
≈ $32.73 Million
0.063x -67.24%
2016-03-31 Rs14.52 Billion
≈ $157.03 Million
Rs2.79 Billion
≈ $30.13 Million
0.192x -16.61%
2015-03-31 Rs12.42 Billion
≈ $134.30 Million
Rs2.86 Billion
≈ $30.91 Million
0.230x -19.70%
2014-03-31 Rs12.02 Billion
≈ $130.01 Million
Rs3.45 Billion
≈ $37.26 Million
0.287x +120.10%
2013-03-31 Rs10.55 Billion
≈ $114.06 Million
Rs1.37 Billion
≈ $14.85 Million
0.130x -21.25%
2012-03-31 Rs9.29 Billion
≈ $100.45 Million
Rs1.54 Billion
≈ $16.61 Million
0.165x -28.31%
2011-03-31 Rs8.79 Billion
≈ $95.08 Million
Rs2.03 Billion
≈ $21.93 Million
0.231x -40.14%
2010-03-31 Rs7.84 Billion
≈ $84.81 Million
Rs3.02 Billion
≈ $32.68 Million
0.385x +105.98%
2009-03-31 Rs7.04 Billion
≈ $76.18 Million
Rs1.32 Billion
≈ $14.25 Million
0.187x +120.69%
2008-03-31 Rs5.73 Billion
≈ $62.02 Million
Rs486.09 Million
≈ $5.26 Million
0.085x -36.93%
2007-03-31 Rs3.18 Billion
≈ $34.39 Million
Rs427.32 Million
≈ $4.62 Million
0.134x +64.50%
2006-03-31 Rs1.89 Billion
≈ $20.39 Million
Rs154.02 Million
≈ $1.67 Million
0.082x +151.73%
2005-03-31 Rs1.47 Billion
≈ $15.91 Million
Rs-232.28 Million
≈ $-2.51 Million
-0.158x --

About Dishman Carbogen Amcis Limited

NSE:DCAL India Biotechnology
Market Cap
$288.43 Million
Rs26.67 Billion INR
Market Cap Rank
#15115 Global
#757 in India
Share Price
Rs170.11
Change (1 day)
+1.35%
52-Week Range
Rs129.97 - Rs314.40
All Time High
Rs389.62
About

Dishman Carbogen Amcis Limited provides contract research and manufacturing services for the pharmaceutical and healthcare industries worldwide. The company operates through Contract Research and Manufacturing Services and Marketable Molecules segments. It offers cholesterol and vitamin D analogs; generic active pharmaceutical ingredients for diagnostics, ophthalmic treatments, laxatives, organop… Read more